Published in Nephrol Dial Transplant on December 01, 2004
Macrophage infiltration into adipose tissue may promote angiogenesis for adipose tissue remodeling in obesity. Am J Physiol Endocrinol Metab (2008) 1.84
Inflammation in diabetic nephropathy. Mediators Inflamm (2012) 1.81
Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism. J Am Soc Nephrol (2006) 1.63
CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease. Am J Pathol (2009) 1.42
Leukocytes induce epithelial to mesenchymal transition after unilateral ureteral obstruction in neonatal mice. Am J Pathol (2007) 1.39
Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis. Front Endocrinol (Lausanne) (2013) 1.34
Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model. Diabetes (2010) 1.29
New insights into the mechanisms of fibrosis and sclerosis in diabetic nephropathy. Rev Endocr Metab Disord (2008) 1.20
Abnormalities in signaling pathways in diabetic nephropathy. Expert Rev Endocrinol Metab (2010) 1.19
The monocyte chemoattractant protein-1/CCR2 loop, inducible by TGF-beta, increases podocyte motility and albumin permeability. Am J Physiol Renal Physiol (2009) 1.17
Diverse functions of matrix metalloproteinases during fibrosis. Dis Model Mech (2014) 1.16
Macrophages produce TGF-beta-induced (beta-ig-h3) following ingestion of apoptotic cells and regulate MMP14 levels and collagen turnover in fibroblasts. J Immunol (2008) 1.11
Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes. Am J Physiol Regul Integr Comp Physiol (2011) 1.11
Curcumin ameliorates macrophage infiltration by inhibiting NF-κB activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy. Nutr Metab (Lond) (2011) 1.10
CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease. J Am Soc Nephrol (2008) 1.08
Fenofibrate attenuates tubulointerstitial fibrosis and inflammation through suppression of nuclear factor-κB and transforming growth factor-β1/Smad3 in diabetic nephropathy. Exp Biol Med (Maywood) (2010) 1.08
Uninephrectomy of diabetic OVE26 mice greatly accelerates albuminuria, fibrosis, inflammatory cell infiltration and changes in gene expression. Nephron Exp Nephrol (2011) 0.86
Urinary protein profiles in a rat model for diabetic complications. Mol Cell Proteomics (2009) 0.85
Induction of hemeoxygenase-1 reduces glomerular injury and apoptosis in diabetic spontaneously hypertensive rats. Am J Physiol Renal Physiol (2011) 0.84
Diabetes and Kidney Disease: Role of Oxidative Stress. Antioxid Redox Signal (2016) 0.83
Induction of hemeoxygenase-1 reduces renal oxidative stress and inflammation in diabetic spontaneously hypertensive rats. Int J Hypertens (2012) 0.83
Proregenerative Microenvironment Triggered by Donor Mesenchymal Stem Cells Preserves Renal Function and Structure in Mice with Severe Diabetes Mellitus. Biomed Res Int (2015) 0.82
CD73-dependent generation of adenosine and endothelial Adora2b signaling attenuate diabetic nephropathy. J Am Soc Nephrol (2013) 0.82
Ruscogenin ameliorates diabetic nephropathy by its anti-inflammatory and anti-fibrotic effects in streptozotocin-induced diabetic rat. BMC Complement Altern Med (2014) 0.81
Effects of Tumor Necrosis Factor-α on Podocyte Expression of Monocyte Chemoattractant Protein-1 and in Diabetic Nephropathy. Nephron Extra (2015) 0.80
Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy. FEBS J (2016) 0.80
Zerumbone, a tropical ginger sesquiterpene, ameliorates streptozotocin-induced diabetic nephropathy in rats by reducing the hyperglycemia-induced inflammatory response. Nutr Metab (Lond) (2013) 0.80
Depletion of cutaneous macrophages and dendritic cells promotes growth of basal cell carcinoma in mice. PLoS One (2014) 0.80
Osteopontin plays a critical role in interstitial fibrosis but not glomerular sclerosis in diabetic nephropathy. Nephron Extra (2012) 0.79
Differential renal effects of candesartan at high and ultra-high doses in diabetic mice-potential role of the ACE2/AT2R/Mas axis. Biosci Rep (2016) 0.77
Renal Protection by Genetic Deletion of the Atypical Chemokine Receptor ACKR2 in Diabetic OVE Mice. J Diabetes Res (2015) 0.77
Rodent animal models: from mild to advanced stages of diabetic nephropathy. Inflammopharmacology (2014) 0.77
Transcriptomic analysis in diabetic nephropathy of streptozotocin-induced diabetic rats. Int J Mol Sci (2011) 0.77
An Aqueous-Ethanol Extract of Liriope spicata var. prolifera Ameliorates Diabetic Nephropathy through Suppression of Renal Inflammation. Evid Based Complement Alternat Med (2013) 0.76
Inhibition of 12/15-Lipoxygenase Reduces Renal Inflammation and Injury in Streptozotocin-Induced Diabetic Mice. J Diabetes Metab (2015) 0.75
Oryeongsan suppressed high glucose-induced mesangial fibrosis. BMC Complement Altern Med (2015) 0.75
Root of Polygonum cuspidatum extract reduces progression of diabetes-induced mesangial cell dysfunction via inhibition of platelet-derived growth factor-BB (PDGF-BB) and interaction with its receptor in streptozotocin-induced diabetic rats. BMC Complement Altern Med (2014) 0.75
Ventral prostate fibrosis in the Akita mouse is associated with macrophage and fibrocyte infiltration. J Diabetes Res (2014) 0.75
Infiltrating macrophages in diabetic nephropathy promote podocytes apoptosis via TNF-α-ROS-p38MAPK pathway. Oncotarget (2017) 0.75
Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol (2003) 4.15
Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial. Am J Kidney Dis (2011) 3.81
Diagnostic accuracy of urine dipsticks for detection of albuminuria in the general community. Am J Kidney Dis (2011) 3.29
Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol (2004) 2.66
Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med (2002) 2.54
Mast cell activation and degranulation promotes renal fibrosis in experimental unilateral ureteric obstruction. Kidney Int (2012) 2.47
Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int (2004) 2.29
Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. J Am Soc Nephrol (2005) 2.23
Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Am J Kidney Dis (2004) 1.94
Inflammation in diabetic nephropathy. Mediators Inflamm (2012) 1.81
Pyridorin in type 2 diabetic nephropathy. J Am Soc Nephrol (2011) 1.79
Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-beta1. Am J Physiol Renal Physiol (2003) 1.79
Smoking is associated with renal impairment and proteinuria in the normal population: the AusDiab kidney study. Australian Diabetes, Obesity and Lifestyle Study. Am J Kidney Dis (2002) 1.78
Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial. J Am Coll Cardiol (2006) 1.67
Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy. J Am Soc Nephrol (2011) 1.66
Disease-dependent mechanisms of albuminuria. Am J Physiol Renal Physiol (2008) 1.64
Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials. Am J Kidney Dis (2004) 1.62
Macrophage accumulation in human progressive diabetic nephropathy. Nephrology (Carlton) (2006) 1.51
Macrophages contribute to cellular but not humoral mechanisms of acute rejection in rat renal allografts. Transplantation (2013) 1.45
Untreated hypertension among Australian adults: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust (2003) 1.44
Native arteriovenous fistula blood flow and resistance during hemodialysis. Am J Kidney Dis (2003) 1.43
Atherosclerosis and folic acid supplementation trial in chronic renal failure: baseline results. Nephrology (Carlton) (2004) 1.38
Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment cO-existing with NIDDM [NEFRON] 11). Diabetes Care (2009) 1.37
Resveratrol inhibits renal fibrosis in the obstructed kidney: potential role in deacetylation of Smad3. Am J Pathol (2010) 1.33
The role of macrophages in allograft rejection. Transplantation (2005) 1.32
Macrophages act as effectors of tissue damage in acute renal allograft rejection. Transplantation (2003) 1.32
Adoptive transfer studies demonstrate that macrophages can induce proteinuria and mesangial cell proliferation. Kidney Int (2003) 1.30
Health-related quality of life in Australian adults with renal insufficiency: a population-based study. Am J Kidney Dis (2003) 1.24
Epidemiology of diabetic nephropathy. Contrib Nephrol (2011) 1.18
Prevention of chronic kidney and vascular disease: toward global health equity--the Bellagio 2004 Declaration. Kidney Int Suppl (2005) 1.16
Alcohol consumption and 5-year onset of chronic kidney disease: the AusDiab study. Nephrol Dial Transplant (2009) 1.14
A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis. J Am Soc Nephrol (2007) 1.13
The role of p38alpha mitogen-activated protein kinase activation in renal fibrosis. J Am Soc Nephrol (2004) 1.12
Limited knowledge of kidney disease in a survey of AusDiab study participants. Med J Aust (2008) 1.11
Blockade of p38alpha MAPK ameliorates acute inflammatory renal injury in rat anti-GBM glomerulonephritis. J Am Soc Nephrol (2003) 1.08
Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation. J Pathol (2012) 1.06
Mitogen activated protein kinases in renal fibrosis. Front Biosci (Schol Ed) (2009) 1.05
Risk factors for peritoneal dialysis-related peritonitis: can we reduce the incidence and improve patient selection? Nephrology (Carlton) (2007) 1.04
Arterial function after successful renal transplantation. Kidney Int (2004) 1.04
Time and exercise improve phosphate removal in hemodialysis patients. Am J Kidney Dis (2004) 1.03
IL-1RI deficiency ameliorates early experimental renal interstitial fibrosis. Nephrol Dial Transplant (2009) 1.03
Identification of alternatively activated macrophages in new-onset paediatric and adult immunoglobulin A nephropathy: potential role in mesangial matrix expansion. Histopathology (2011) 1.02
TGF-β1-activated kinase-1 regulates inflammation and fibrosis in the obstructed kidney. Am J Physiol Renal Physiol (2011) 1.01
In vivo visualization of albumin degradation in the proximal tubule. Kidney Int (2008) 1.01
Does monthly native arteriovenous fistula blood-flow surveillance detect significant stenosis--a randomized controlled trial. Nephrol Dial Transplant (2006) 1.00
Activation of the extracellular-signal regulated protein kinase pathway in human glomerulopathies. J Am Soc Nephrol (2004) 1.00
The effects of a low-carbohydrate ketogenic diet and a low-fat diet on mood, hunger, and other self-reported symptoms. Obesity (Silver Spring) (2007) 0.99
Activation of the ERK pathway precedes tubular proliferation in the obstructed rat kidney. Kidney Int (2003) 0.99
A quarter of a century of adult peritoneal dialysis-related peritonitis at an Australian medical center. Perit Dial Int (2007) 0.98
Contrasting effects of steroids and mizoribine on macrophage activation and glomerular lesions in rat thy-1 mesangial proliferative glomerulonephritis. Am J Nephrol (2010) 0.97
Macrophage accumulation at a site of renal inflammation is dependent on the M-CSF/c-fms pathway. J Leukoc Biol (2002) 0.97
Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis. J Am Soc Nephrol (2002) 0.97
Blood pressure lowering for the prevention and treatment of diabetic kidney disease. Drugs (2006) 0.97
Indoleamine 2,3-dioxygenase in transplantation. Nephrology (Carlton) (2008) 0.97
Histological differences in new-onset IgA nephropathy between children and adults. Nephrol Dial Transplant (2006) 0.96
Induction of MIF synthesis and secretion by tubular epithelial cells: a novel action of angiotensin II. Kidney Int (2003) 0.96
Tim-1 promotes cisplatin nephrotoxicity. Am J Physiol Renal Physiol (2011) 0.96
Heterogeneity of antigen expression explains controversy over glomerular macrophage accumulation in mouse glomerulonephritis. Nephrol Dial Transplant (2003) 0.96
Activation and cellular localization of the p38 and JNK MAPK pathways in rat crescentic glomerulonephritis. Kidney Int (2003) 0.95
p38 Mitogen-activated protein kinase activation and cell localization in human glomerulonephritis: correlation with renal injury. J Am Soc Nephrol (2004) 0.95
Kidney expression of glutathione peroxidase-1 is not protective against streptozotocin-induced diabetic nephropathy. Am J Physiol Renal Physiol (2005) 0.95
The role of macrophage migration inhibitory factor in autoimmune liver disease. Hepatology (2013) 0.95
Blockade of the c-Jun amino terminal kinase prevents crescent formation and halts established anti-GBM glomerulonephritis in the rat. Lab Invest (2009) 0.94
Alternatively activated macrophages in the pathogenesis of chronic kidney allograft injury. Pediatr Nephrol (2014) 0.94
Blockade of macrophage colony-stimulating factor reduces macrophage proliferation and accumulation in renal allograft rejection. Am J Transplant (2003) 0.92
Activated macrophages down-regulate podocyte nephrin and podocin expression via stress-activated protein kinases. Biochem Biophys Res Commun (2008) 0.92
MKK3 signalling plays an essential role in leukocyte-mediated pancreatic injury in the multiple low-dose streptozotocin model. Lab Invest (2008) 0.91
Endogenous Tim-1 (Kim-1) promotes T-cell responses and cell-mediated injury in experimental crescentic glomerulonephritis. Kidney Int (2011) 0.91
The sialoadhesin (CD169) expressing a macrophage subset in human proliferative glomerulonephritis. Nephrol Dial Transplant (2005) 0.91
Diabetic kidney disease: act now or pay later. Acta Diabetol (2010) 0.90
Mast cells mediate acute kidney injury through the production of TNF. J Am Soc Nephrol (2011) 0.89
Role of macrophages in the fibrotic phase of rat crescentic glomerulonephritis. Am J Physiol Renal Physiol (2013) 0.89
Interferon-gamma augments acute macrophage-mediated renal injury via a glucocorticoid-sensitive mechanism. J Am Soc Nephrol (2003) 0.89
Macrophage-mediated renal injury is dependent on signaling via the JNK pathway. J Am Soc Nephrol (2004) 0.89
Population prevalence of albuminuria in the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study: immunonephelometry compared with high-performance liquid chromatography. Am J Kidney Dis (2006) 0.89
Television viewing time and risk of chronic kidney disease in adults: the AusDiab Study. Ann Behav Med (2010) 0.88